NCT01229566 Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia Status UNKNOWN Phase PHASE3
NCT01208961 Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation Status COMPLETED Phase PHASE2